Get started
Author

L. C. Pronk

Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy
1998 · M. J. van den Bent, J. M. Kros, et al. · Neurology · 206
A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours
2000 · L C Pronk, P Vasey, et al. · British Journal of Cancer · 97
PDF
Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin
1997 · PHE Hilkens, LC Pronk, et al. · British Journal of Cancer · 75
PDF
A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumours
2007 · G Attard, J Kitzen, et al. · British Journal of Cancer · 70
PDF
Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors.
1997 · L C Pronk, J H Schellens, et al. · Journal of Clinical Oncology · 67
Increases in leucocyte and platelet counts induced by the alkyl phospholipid hexadecylphosphocholine
1994 · L.C. Pronk, A.S.Th. Planting, et al. · European Journal of Cancer · 28
Corticosteroid co-medication does not reduce the incidence and severity of neurotoxicity induced by docetaxel
1998 · LC Pronk, PHE Hilkens, et al. · Anti-Cancer Drugs · 22
Pulmonary hypertension in connective tissue disease
1991 · L. C. Pronk, A. J. G. Swaak · Rheumatology International · 22
Pharmacokinetics of Ifosfamide Are Changed by Combination With Docetaxel
2000 · D. Schrijvers, L. Pronk, et al. · American Journal of Clinical Oncology · 21
Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours
1998 · LC Pronk, D Schrijvers, et al. · British Journal of Cancer · 21
Phase II Study of Weekly Dose-intensified Cisplatin Chemotherapy with Oral Etoposide in Recurrent Glioma
1999 · M.J. van den Bent, L. Pronk, et al. · Journal of Neuro-Oncology · 12
Docetaxel in 253 previously treated patients with progressive locally advanced or metastatic breast cancer: results of a compassionate use program in The Netherlands
2000 · C MF Kruijtzer, J Verweij, et al. · Anti-Cancer Drugs · 10
A phase Ib study of pertuzumab (P), a recombinant humanized antibody to HER2, and docetaxel (D) in patients (pts) with advanced solid tumors
2005 · G. Attard, J. J. Kitzen, et al. · Journal of Clinical Oncology · 8
Phase I/II trial of irinotecan plus high-dose 5-fluorouracil (TTD regimen) as first-line chemotherapy in advanced colorectal cancer
2004 · E. Aranda, A. Carrato, et al. · Annals of Oncology · 6
PDF
A phase I dose escalation study of the LRP5 antagonist BI 905681 in patients with advanced and metastatic solid tumors
2024 · D.R. Spigel, J.S. Wang, et al. · ESMO Open · 5
PDF
The venotonic drug hydroxyethylrutosiden does not prevent or reduce docetaxel-induced fluid retention: results of a comparative study
1999 · L. C. Pronk, W. L. J. van Putten, et al. · Cancer Chemotherapy and Pharmacology · 5
Docetaxel and ifosfamide in patients with advanced solid tumors: results of a phase I study.
1998 · L C Pronk, D Schrijvers, et al. · PubMed · 4
Phase I and pharmacokinetic study of XelodaTM (capecitabine) in combination with docetaxel
1997 · P.A. Vasey, L. Pronk, et al. · European Journal of Cancer · 3
Traficet-EN (CCX282-B), an orally active inhibitor of chemokine receptor CCR9, for treatment of Crohnʼs disease
2007 · P Bekker, A te Velde, et al. · Inflammatory Bowel Diseases · 2
287 A phase Ib study of pertuzumab (P), a recombinant humanized antibody to HER2, and capecitabine (C) in patients with advanced solid tumors
2004 · J.W. Valle, C. Montagut, et al. · European Journal of Cancer Supplements · 1
1441TiP An open-label, phase Ib trial to assess the safety and efficacy of SIRPα monoclonal antibody BI 770371 in combination with pembrolizumab with or without cetuximab compared with pembrolizumab monotherapy for the first-line treatment of patients with head and neck squamous cell carcinoma (NCT06806852)
2025 · S. Laban, S. Osinowo, et al. · Annals of Oncology
PDF
Js07.4.a a Phase 0/ia Study of Brigimadlin Concentration in Brain Tissue and a Dose Escalation Study of Brigimadlin Plus Radiotherapy in Patients With Newly Diagnosed Glioblastoma
2024 · J N Sarkaria, M M Mrugala, et al. · Neuro-Oncology
PDF
Phase I study on docetaxel and ifosfamide in patients with advanced solid tumors
1997 · L.C. Pronk, D. Schrijvers, et al. · Lung Cancer
Works count: 24
Citation count: 685
H-index: 11
I10-index: 12
Year
Topic
Type